The company has come a long way from a Soviet enterprise to a modern hi-tech pharmaceutical plant. Over the past decade, Darnitsa modernized all its core and ancillary manufacturing facilities, built a robotic warehouse complex for 10,000 pallet positions, invested over €200 million in production, implemented an automated manufacturing planning system, and obtained a GMP certificate.
Such an approach allowed Darnitsa to take the lead among national pharmaceutical producers and become number one in the sales of prepackaged medications in Ukraine.
